Brief: Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results And Recent Business Highlights
13/05/2026 22:55
May 13 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O: ELEDON PHARMACEUTICALS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS Source text: ID:nGNX2FbTf9 Further company coverage: ELDN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial